Vyepti is a medicine used to prevent migraine in adults who have migraines at least 4 days a month. Vyepti contains the active substance eptinezumab.
Therapeutic Indication
### Therapeutic indication Vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
Therapeutic Area (MeSH)
ATC Code
N02CD
ATC Item
降钙素基因相关肽（CGRP）拮抗剂
Pharmacotherapeutic Group
Analgesics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Eptinezumab | N/A | Eptinezumab |
EMA Name
Vyepti
Medicine Name
Vyepti
Aliases
N/A
